Haejung Won

Haejung Won is currently the Associate Director at InduPro, specializing in cancer immunotherapy drug development. They previously served as a Principal Scientist at Pfizer, where they led projects translating scientific discoveries into clinical advancements. Haejung's earlier experience includes positions at Bristol-Myers Squibb as a Research Investigator I and as a Postdoctoral Fellow at the City of Hope, where they investigated immune modulation and biomarkers in cancer therapies. Haejung earned a Ph.D. in Immunology from the University of Southern California after obtaining a bachelor's degree in Biology from Korea University.